UK-based pharmaceutical drug discovery company IsoChemiX is developing molecules which will have the ability to cut both the time and cost of bringing a new drug to market.
The R&D process for a new drug is known to take between 10-15 years, with the cost of preclinical testing reaching £1.2bn-1.64bn to get the drug from the lab to the market. IsoChemiX say its product will make the process faster by six months and reduce the overall cost by up to £87m.
